Evidence map›Paper›PMID 32351987›Full record

ReviewBioMed research international2020

Investigating Tunneling Nanotubes in Cancer Cells: Guidelines for Structural and Functional Studies through Cell Imaging.

Fatéméh Dubois, Magalie Bénard, Bastien Jean-Jacques, Damien Schapman, Hélène Roberge, Alexis Lebon, Didier Goux, Baptiste Monterroso, Nicolas Elie, Hitoshi Komuro and 5 more

Open access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Tunneling Nanotubes: The Cables for Viral Spread and Beyond.Results and problems in cell differentiation · 2024
    Review
  10. Review
  11. Article
  12. Review
  13. Microbiology spectrum · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Tunneling Nanotubes: A New Target for Nanomedicine?International journal of molecular sciences · 2022
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Fatéméh DuboisNormandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, F-14000 Caen, France GIP CYCERON.
Magalie BénardNormandie University, UNIROUEN, INSERM, PRIMACEN, F-76821 Mont-Saint-Aignan, France.
Bastien Jean-JacquesNormandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, F-14000 Caen, France GIP CYCERON.
Damien SchapmanNormandie University, UNIROUEN, INSERM, PRIMACEN, F-76821 Mont-Saint-Aignan, France.
Hélène RobergeNormandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, F-14000 Caen, France GIP CYCERON.
Alexis LebonNormandie University, UNIROUEN, INSERM, PRIMACEN, F-76821 Mont-Saint-Aignan, France.
Didier GouxNormandie Université, UNICAEN, SFR ICORE, Plateau CMABio3, F-14032 Caen, France.
Baptiste MonterrosoNormandie University, UNIROUEN, INSERM, PRIMACEN, F-76821 Mont-Saint-Aignan, France.
Nicolas ElieNormandie Université, UNICAEN, SFR ICORE, Plateau CMABio3, F-14032 Caen, France.
Hitoshi KomuroDepartment of Neuroscience, School of Medicine, Yale University, New Haven, CT 06510, USA.
Céline BazilleNormandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, F-14000 Caen, France GIP CYCERON.
Jérôme LevalletNormandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, F-14000 Caen, France GIP CYCERON.ORCID https://orcid.org/0000-0003-4133-2813
Emmanuel BergotNormandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, F-14000 Caen, France GIP CYCERON.
Guénaëlle LevalletNormandie Université, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, F-14000 Caen, France GIP CYCERON.ORCID https://orcid.org/0000-0001-7772-0581
Ludovic GalasNormandie University, UNIROUEN, INSERM, PRIMACEN, F-76821 Mont-Saint-Aignan, France.ORCID https://orcid.org/0000-0002-7374-0769
Centre National de la Recherche Scientifique · FRInserm · FRNormandie Université · FRYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By allowing insured communication between cancer cells themselves and with the neighboring stromal cells, tunneling nanotubes (TNTs) are involved in the multistep process of cancer development from tumorigenesis to the treatment resistance. However, despite their critical role in the biology of cancer, the study of the TNTs has been announced challenging due to not only the absence of a specific biomarker but also the fragile and transitory nature of their structure and the fact that they are hovering freely above the substratum. Here, we proposed to review guidelines to follow for studying the structure and functionality of TNTs in tumoral neuroendocrine cells (PC12) and nontumorigenic human bronchial epithelial cells (HBEC-3, H28). In particular, we reported how crucial is it (i) to consider the culture conditions (culture surface, cell density), (ii) to visualize the formation of TNTs in living cells (mechanisms of formation, 3D representation), and (iii) to identify the cytoskeleton components and the associated elements (categories, origin, tip, and formation/transport) in the TNTs. We also focused on the input of high-resolution cell imaging approaches including Stimulated Emission Depletion (STED) nanoscopy, Transmitted and Scanning Electron Microscopies (TEM and SEM). In addition, we underlined the important role of the organelles in the mechanisms of TNT formation and transfer between the cancer cells. Finally, new biological models for the identification of the TNTs between cancer cells and stromal cells (liquid air interface,

Indexed as

Cell CommunicationElectron Microscope TomographyMicroscopy, Electron, ScanningMicrotubulesNeoplasmsAnimalsHumansPC12 CellsRats

Identifiers

PMID32351987
PMCPMC7174938
OpenAlexW3015784633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.